Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D002277:Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000000981:diagnostic imaging / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005340:Fibrinogen / Q000032:analysis; D005472:Fluorouracil / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011859:Radiography; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D013866:Thioguanine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D005340:Fibrinogen; D006493:Heparin; D013866:Thioguanine; D005472:Fluorouracil; D008727:Methotrexate